A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

Journal of the National Cancer Institute

Volumn 99, Issue 11, 2007, Pages 858-867

  Yanagisawa, Kiyoshi ^a   Tomida, Shuta ^a   Shimada, Yukako ^a   Yatabe, Yasushi ^a   Mitsudomi, Tetsuya ^a   Takahashi, Takashi ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; TUMOR RECURRENCE;

CARCINOMA, NON-SMALL-CELL LUNG; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34347394769     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk197     Document Type: Article

References (0)